Abstract
Fatty liver in obese patients is emerging as one of the most common causes of chronic liver disease. Obese patients are at risk of developing type 2 diabetes mellitus (DM), and aggravating non-alcoholic fatty liver disease (NAFLD), developing into steatohepatitis (NASH) and hepatic fibrosis. Little is known of the possible impact on liver fibrogenesis of diabetes type 2 associated with obesity and NAFLD. Fifty-two morbidly obese patients were evaluated with complete clinical and laboratory medical assessment. Liver biopsy material was fixed in formalin, routinely processed to paraffin blocks, cut into 4-μm sections, stained with HE, PAS, Masson’s trichrome and reticulin. Immunohistochemical stains included collagen IV, SMA and laminin. Within the initial group of 52, 25 patients had DM type 2, mean age 45.8 years. Patients with diabetes were older; had higher BMI, liver enzyme tests, glucose, cholesterol, and triglycerides; and lower albumin concentration. Livers of diabetics had significantly more severe steatosis and rich perisinusoidal collagen IV, laminin and SMA accumulation without histologically detectable NASH and irrespective of the degree of steatosis. Obese patients with type 2 DM and insulin resistance develop more severe NAFLD and early sinusoidal fibrosclerosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lonardo A, Lombardini S, Scaglioni F et al (2006) Hepatic steatosis and insulin resistance: does etiology make a difference? J Hepatol 44:190–196
Raman M, Allard J (2006) Non alcoholic fatty liver disease: a clinical approach and review. Can J Gastroenterol 20:345–349
Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40:S5–S10
Targher G, Bertolini L, Padovani R et al (2006) Increased prevalence of cardiovascular disease in type 2 diabetic patients with non-alcoholic liver disease. Diabet Med 23:403–409
Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough J (2004) Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2:262–265
Feldstein AE, Papouchado G, Angulo P et al (2005) Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 3:384–389
Brunt EM (2005) Pathology of nonalcoholic steatohepatitis. Hepatol Res 33:68–71
Schmitt-Graff A, Kruger S, Bochard F et al (1991) Modulation of smooth muscle actin and desmin expression in perisinusoidal cells in normal and diseased human livers. Am J Pathol 138:1233–1242
Brunt EM, Neuschwander-Tetri BA, Oliver D et al (2004) Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 35:1070–1082
Harrison SA, Brunt EM, Goodman ZD, Bisceglie AM (2006) Diabetic hepatosclerosis. Arch Pathol Lab Med 130:27–30
Jaskiewicz K, Raczynska S, Rzepko R, Sledzinski Z (2006) Nonalcoholic fatty liver disease treated by gastroplasty. Dig Dis Sci 51:21–26
Raman M, Allard J (2006) Non alcoholic fatty liver disease: a clinical approach and review. Can J Gastroenterol 20:345–349
Davi G, Chiarelli F, Santilli F et al (2003) Enhanced lipid peroxidation and platelet activation in the early phase of type I diabetes mellitus: role of interleukin-6 and disease duration. Circulation 107:3199–3203
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jaskiewicz, K., Rzepko, R. & Sledzinski, Z. Fibrogenesis in Fatty Liver Associated with Obesity and Diabetes Mellitus Type 2. Dig Dis Sci 53, 785–788 (2008). https://doi.org/10.1007/s10620-007-9942-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-007-9942-x